विवरण
Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons.
Figure 22
ChartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 22: Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons." /> <figcaption>Figure 22. Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
संबंधित साक्ष्य
B
Bifidobacterium longum के लिए Irritable Bowel Syndrome (IBS)
B
ग्रेड B · 4 अध्ययन
Galactooligosaccharides (GOS) के लिए Irritable Bowel Syndrome (IBS)
B
ग्रेड B · 3 अध्ययन
Lactobacillus acidophilus के लिए Irritable Bowel Syndrome (IBS)
D
ग्रेड B · 3 अध्ययन
Fructooligosaccharides (FOS) के लिए Irritable Bowel Syndrome (IBS)
ग्रेड D · 2 अध्ययन